The WACC of Nirvana Life Sciences Inc (NIRV.CN) is 14.5%.
| Range | Selected | |
| Cost of equity | 14.70% - 18.00% | 16.35% |
| Tax rate | 25.90% - 26.50% | 26.20% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 13.1% - 15.9% | 14.5% |
| Category | Low | High |
| Long-term bond rate | 3.2% | 3.7% |
| Equity market risk premium | 5.1% | 6.1% |
| Adjusted beta | 2.27 | 2.27 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 14.70% | 18.00% |
| Tax rate | 25.90% | 26.50% |
| Debt/Equity ratio | 0.18 | 0.18 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 13.1% | 15.9% |
| Selected WACC | 14.5% | |